Top

Trials

Published in:

Open Access 01-12-2011 | Study protocol

The serious mental illness health improvement profile [HIP]: study protocol for a cluster randomised controlled trial

Authors: Jacquie White, Richard J Gray, Louise Swift, Garry R Barton, Martin Jones

Published in: Trials | Issue 1/2011

Abstract

Background

The serious mental illness Health Improvement Profile [HIP] is a brief pragmatic tool, which enables mental health nurses to work together with patients to screen physical health and take evidence-based action when variables are identified to be at risk. Piloting has demonstrated clinical utility and acceptability.

Methods/Design

A single blind parallel group cluster randomised controlled trial with secondary economic analysis and process observation. Unit of randomisation: mental health nurses [MHNs] working in adult community mental health teams across two NHS Trusts. Subjects: Patients over 18 years with a diagnosis of schizophrenia, schizoaffective or bipolar disorder on the caseload of participating MHNs. Primary objective: To determine the effects of the HIP programme on patients' physical wellbeing assessed by the physical component score of the Medical Outcome Study (MOS) 36 Item Short Form Health Survey version 2 [SF-36v2]. Secondary objectives: To determine the effects of the HIP programme on: cost effectiveness, mental wellbeing, cardiovascular risk, physical health care attitudes and knowledge of MHNs and to determine the acceptability of the HIP Programme in the NHS. Consented nurses (and patients) will be randomised to receive the HIP Programme or treatment as usual. Outcomes will be measured at baseline and 12 months with a process observation after 12 months to include evaluation of patients' and professionals' experience and observation of any effect on care plans and primary-secondary care interface communication. Outcomes will be analysed on an intention-to-treat (ITT) basis.

Discussion

The results of the trial and process observation will provide information about the effectiveness of the HIP Programme in supporting MHNs to address physical comorbidity in serious mental illness. Given the current unacceptable prevalence of physical comorbidity and mortality in the serious mental illness population, it is hoped the HIP trial will provide a timely contribution to evidence on organisation and delivery of care for patients, clinicians and policy makers.

Trial Registration

ISRCTN: ISRCTN41137900

Available only for authorised users

Department of Health: Choosing Health: Supporting the physical needs of people with severe mental illness Commissioning Framework. 2006, London: Department of Health

Department of Health: New Horizons, A shared vision for mental health. 2009, London: Department of Health

Colton CW, Manderscheid RW: Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease. 2006, 3: 1-14. 10.1191/1479972306cd086ed.

Roshanaei-Moghaddam B, Katon W: Premature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review. Psychiatric Services. 2009, 60: 147-156. 10.1176/appi.ps.60.2.147.CrossRefPubMed

Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis B, Stroup S, Lieberman JA: Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research. 2006, 86: 15-22. 10.1016/j.schres.2006.06.026.CrossRefPubMed

McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Stroup S, Lieberman JA: Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research. 2005, 80: 19-32. 10.1016/j.schres.2005.07.014.CrossRefPubMed

Haddad P: Weight change with atypical antipsychotics in the treatment of schizophrenia. Journal of Psychopharmacology. 2005, 19 (6 Suppl): s16-s27. 10.1177/0269881105058378.CrossRef

Robson D, Gray R: Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies. 2007, 44: 457-466. 10.1016/j.ijnurstu.2006.07.013.CrossRefPubMed

Shahzad S, Suleman MI, Shahab H, Mazour I, Kaur A, Rudzinskiy P, Lippmann S: Cataract Occurrence With Antipsychotic Drugs. Psychosomatics. 2002, 43 (5): 354-359. 10.1176/appi.psy.43.5.354.CrossRefPubMed

10.

Halbreich U, Kahn LS: Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects. Journal of Psychiatric Practice. 2003, 9: 344-351. 10.1097/00131746-200309000-00003.CrossRefPubMed

11.

Freidlander AH, Marder SR: The psychopathology, medical management and dental implications of schizophrenia. Journal of the American Dental Association. 2002, 133: 603-610.CrossRef

12.

Gournay K: Setting clinical standards for care on schizophrenia. Nursing Times. 1996, 92: 36-37.PubMed

13.

Phelan M, Stradins L, Morrison S: Physical health of people with severe mental illness. BMJ. 2001, 322: 443-444. 10.1136/bmj.322.7284.443.CrossRefPubMedPubMedCentral

14.

Disability Rights Commission: Equal Treatment:Closing the Gap. 2006, London: Disability Rights Commission

15.

Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S: Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry. 2004, 161: 1334-1349. 10.1176/appi.ajp.161.8.1334.CrossRefPubMed

16.

National Institute of Health and Clinical Excellence: Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care NICE clinical guideline 1. 2002, London: NICE

17.

National Institute of Health and Clinical Excellence: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care NICE clinical guideline 38. 2006, London: NICE

18.

National Institute of Health and Clinical Excellence: Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). 2009, London: NICE

19.

Tosh G, Clifton A, Mala S, Bachner M: Physical health care monitoring for people with serious mental illness. Cochrane Database Syst Rev. 2010, 17 (3): CD008298-

20.

Burns T, Cohen A: Item of service payments for general practitioner care of severely mentally ill persons: does the money matter?. British Journal of General Practice. 1998, 48 (432): 1415-6.PubMedPubMedCentral

21.

Paton C, Esop R, Young C, Taylor D: Obesity, dyslipidaemias and smoking in an in-patient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica. 2004, 110: 299-305. 10.1111/j.1600-0447.2004.00372.x.CrossRefPubMed

22.

Barnes TRE, Paton C, Hancock E, Cavanagh MT, Taylor D, Lelliott P, on behalf of the UK Prescribing Observatory for Mental Health: Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatrica Scandinavica. 2008, 118 (1): 26-33. 10.1111/j.1600-0447.2008.01203.x.CrossRefPubMed

23.

Healthcare Commission: No Voice, No Choice: A joint review of adult community mental health services in England. 2007, London: Healthcare Commission

24.

Eldridge D, Dawber N, Gray R: A well-being support program for patients with severe mental illness: a service evaluation. BMC Psychiatry. 2011, 11: 46-10.1186/1471-244X-11-46.CrossRefPubMedPubMedCentral

25.

Department of Health: From Values to Action: The Chief Nursing Officer's review of mental health nursing. 2006, London: Department of Health

26.

Nash M: Physical care skills: a training needs analysis of inpatient and community mental health nurses. Mental Health Practice. 2005, 9 (4): 20-3.CrossRef

27.

Gray R, Wykes T, Gournay K: The effect of medication management training on community mental health nurse's clinical skills. International Journal of Nursing Studies. 2003, 40: 163-169. 10.1016/S0020-7489(02)00045-7.CrossRefPubMed

28.

Gray R, Wykes T, Edmonds M, Leese M, Gournay K: Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: Cluster randomised controlled trial. British Journal of Psychiatry. 2004, 185: 157-162. 10.1192/bjp.185.2.157.CrossRefPubMed

29.

Jordan S, Tunnicliffe C, Sykes A: Minimizing side-effects: the clinical impact of nurse-administered 'side-effect' checklists. Journal of Advanced Nursing. 2002, 37: 155-165. 10.1046/j.1365-2648.2002.02064.x.CrossRefPubMed

30.

Morrison P, Meehan T, Gaskill D, Lunney P, Collings P: Enhancing case managers' skills in the assessment and management of antipsychotic medication side-effects. Australian and New Zealand Journal of Psychiatry. 2000, 34: 814-821.CrossRefPubMed

31.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P: Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. British Medical Journal. 2008, 336 (7659): 1475-1482. 10.1136/bmj.39609.449676.25.CrossRefPubMedPubMedCentral

32.

Shuel F, White J, Jones M, Gray R: Using the serious mental illness health improvement profile [HIP] to identify physical problems in a cohort of community patients: A pragmatic case series evaluation. International Journal of Nursing Studies. 2010, 47 (2): 136-145. 10.1016/j.ijnurstu.2009.06.003.CrossRefPubMed

33.

Campbell MK, Elbourne DR, Altman DG: CONSORT statement: extension to cluster randomised trials. BMJ. 2004, 328: 702-708. 10.1136/bmj.328.7441.702.CrossRefPubMedPubMedCentral

34.

Ware JE: User's manual for the SF36v2 health survey - second edition. 2007, Lincoln RI: Quality Metric Inc

35.

Ware JE: SF-36 Health Survey Update. The Use of Psychological testing For Treatment Planning and Outcomes Assessment. Edited by: Maruish ME, Mahwah NJ. 2004, Lawrence Erlbaum Associates, 3: 693-718. Third

36.

Russo J, Trujillo CA, Wingerson D, Decker K, Ries R, Wetzler H, Roy-Byrne P: The MOS 36-Item Short Form Health Survey: Reliability, Validity, and Preliminary Findings in Schizophrenia Outpatients. Medical Care. 1998, 36: 752-756. 10.1097/00005650-199805000-00015.CrossRefPubMed

37.

Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D: Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis. Schizophrenia Research. 2009, 112: 158-163. 10.1016/j.schres.2009.03.041.CrossRefPubMed

38.

Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Van Wijngaarden B: Client Socio-Demographic and Services Receipt Inventory-European Version: development of an instrument for international research EPSILON Study 5. British Journal of Psychiatry. 2000, 177: s28-s33. 10.1192/bjp.177.39.s28.CrossRef

39.

The EuroQol Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.CrossRef

40.

Robson D, Haddad M: Mental Health Nurse Physical Health Attitude Scale [PHASe]. 2010, Institute of Psychiatry, Kings College London, King's Health Partners

41.

QRISK^® 2010 Annual Release 2010 Documentation. http://www.qrisk.org/QRISK2%202010%20Annual%20Update%20Information.pdf

42.

Norfolk and Waveney Mental Health NHS Foundation Trust: Consent to Examination and Treatment Policy C71: Version 2. 2005, Norfolk: NWMHFT

43.

White J, Gray R, Jones M: The development of the serious mental illness physical Health Improvement Profile. Journal of Psychiatric and Mental Health Nursing. 2009, 16: 493-498. 10.1111/j.1365-2850.2009.01375.x.CrossRefPubMed

44.

Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Trials. 2010, 11: 32-10.1186/1745-6215-11-32.CrossRefPubMedPubMedCentral

45.

Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Alman DG: CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: c869-10.1136/bmj.c869.CrossRefPubMedPubMedCentral

46.

Guest G, Bunce A, Johnson L: How Many Interviews are Enough? An Experiment with Data Saturation and Variability. Field Methods. 2006, 18: 59-82. 10.1177/1525822X05279903.CrossRef

47.

National Institute of Health and Clinical Excellence: Guide to the Methods of Technology Appraisal. 2008, London: NICE

48.

Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed

49.

Barton GR, Briggs AH, Fenwick EA: Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health. 2008, 11 (5): 886-897. 10.1111/j.1524-4733.2008.00358.x.CrossRefPubMed

50.

Braun V, Clark V: Using Thematic Analysis in psychology. Qualitative Research in Psychology. 2006, 3: 77-101.CrossRef

51.

Lincoln YS, Guba EG: Naturalistic Enquiry. 1985, Newbury Park CA: Sage

52.

Nash M: Assessing nurses' propositional knowledge of physical health. Mental Health Practice. 2010, 14: 20-23.CrossRef

53.

Osborn D, Nazareth I, Wright C, King M: Impact of a nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomised feasibility trial of community mental health teams. BMC Health Services Research. 2010, 10: 61-10.1186/1472-6963-10-61.CrossRefPubMedPubMedCentral

54.

Smith S, Yeomans D, Bushe CJP, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G: A well-being programme in severe mental illness. Baseline findings in a UK cohort. International Journal of Clinical Practice. 2007, 61: 1971-1978. 10.1111/j.1742-1241.2007.01605.x.CrossRefPubMedPubMedCentral

55.

Smith S, Yeomans D, Bushe CJP, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G: A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2 years. European Psychiatry. 2007, 22 (7): 413-418. 10.1016/j.eurpsy.2007.07.002.CrossRefPubMed

56.

Council MR: Developing and evaluating complex interventions: new guidance. 2009, Medical Research Council

Title: The serious mental illness health improvement profile [HIP]: study protocol for a cluster randomised controlled trial
Authors: Jacquie White
Richard J Gray
Louise Swift
Garry R Barton
Martin Jones
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Trials / Issue 1/2011
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/1745-6215-12-167

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The serious mental illness health improvement profile [HIP]: study protocol for a cluster randomised controlled trial

Abstract

Background

Methods/Design

Discussion

Trial Registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods/Design

Discussion

Trial Registration

Please log in to get access to this content

Other articles of this Issue 1/2011

The effect of five years versus two years of specialised assertive intervention for first episode psychosis - OPUS II: study protocol for a randomized controlled trial

A cluster-randomized, placebo-controlled, maternal vitamin a or beta-carotene supplementation trial in bangladesh: design and methods

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication

Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians)

Effects of acupuncture on patients with fibromyalgia: study protocol of a multicentre randomized controlled trial

A Meta-analysis of the effects of Exercise Training on Left Ventricular Remodeling Following Myocardial Infarction: Start early and go longer for greatest exercise benefits on remodeling